CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE
Clinical trials for CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Poop pills or transplants: do they really work Long-Term? 4,000-Patient study aims to find out
Disease control Recruiting nowThis study is following about 4,000 people who have received a fecal microbiota transplant (FMT) to see how well it works over time and if it's safe. FMT involves putting healthy donor stool into a patient's gut to restore good bacteria. The study looks at conditions like severe …
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE
Sponsor: Chen QiYi • Aim: Disease control
Last updated May 26, 2026 04:43 UTC
-
Poop pills? no, a stool transplant via colonoscopy to fight superbug
Disease control Recruiting nowThis study tests whether a stool transplant (fecal microbiota transplantation) given during a colonoscopy can stop repeat Clostridium difficile (C. diff) infections. About 500 people who have had two or more C. diff recurrences and failed standard antibiotics will receive a stool…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE
Phase: NA • Sponsor: Krunal Patel • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
Could a 14-Day pill break the cycle of recurrent c. diff?
Prevention Recruiting nowThis study tests a new treatment called VE303 to see if it can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had C. diff before will take either VE303 or a placebo for 14 days. The main goal is to see if fewer people get another C. diff i…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention
Last updated May 26, 2026 04:43 UTC